Cargando…
Inhaled GM-CSF in neonatal mice provides durable protection against bacterial pneumonia
Pneumonia poses profound health threats to preterm infants. Alveolar macrophages (AMs) eliminate inhaled pathogens while maintaining surfactant homeostasis. As AM development only occurs perinatally, therapies that accelerate AM maturation in preterms may improve outcomes. We tested therapeutic resc...
Autores principales: | Todd, Elizabeth M., Ramani, Rashmi, Szasz, Taylor P., Morley, S. Celeste |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693910/ https://www.ncbi.nlm.nih.gov/pubmed/31453341 http://dx.doi.org/10.1126/sciadv.aax3387 |
Ejemplares similares
-
Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
por: Bosteels, Cedric, et al.
Publicado: (2022) -
Delivery of GM-CSF to Protect against Influenza Pneumonia
por: Subramaniam, Renuka, et al.
Publicado: (2015) -
Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies
por: Bonaventura, Aldo, et al.
Publicado: (2020) -
GM-CSF in inflammation
por: Hamilton, John A.
Publicado: (2019) -
G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990)